Thailand to Test Mahidol-Developed Dengue Vaccine Prototype
Posted on: Monday, 5 September 2005, 09:00 CDT
Thailand to test Mahidol-developed dengue vaccine prototype
BANGKOK, Sept. 4 (Xinhua) -- Thai researchers have planned to test a dengue fever vaccine on 3,000-5,000 human volunteers within the next three years after having successfully conducted tests on animals and a small group of human volunteers, Thai News Agency reported Sunday.
Dengue fever is an infectious disease carried by mosquitoes and caused by any of four related dengue viruses. A patient develops high fever, rash, headaches and severe muscle and joint pains.
Prof. Suthee Yoksan, director of Mahidol University's Vaccine Development Center for Research said the center has developed a vaccine which may help prevent infection from all four strains of dengue virus.
The Mahidol vaccine was first successfully tested with laboratory animals. Further tests with between some 200 children and adults found that just one-shot of the vaccine helps develop immunity in the small group of volunteers and that prevents virus infection.
In the next stage, or phrase three, Prof. Suthee said, his team will produce a larger amount of the vaccine to use on tests with a large group of between 3,000-5,000 volunteers in the central province of Ratchaburi. This is expected to be completed in 2007.
Dengue has infected 7,200 people in Thailand as of early May 2005, of whom 12 have died, up from seven deaths in the same period last year, according to Department of Disease Control chief Thawat Suntrajarn.
Source: Xinhua News Agency - CEIS
Related Articles
- Entrust Earns SC Magazine Accolade in Authentication Group Test
- AVG Named 'Recommended' in Anti-malware Group Test
- New Cancer Study Seeks 300,000 Volunteers to Provide Insight
- Closing in on 9,000 Volunteer Hours, Local Students Awarded Scholarships By Kaiser Permanente's Watts Counseling & Learning Center
- Bird Flu Vaccine Headed for Final Round of Testing
- Xirrus XS-3900 Wi-Fi Array Verified to Support More Than 1,000 Users in Tolly Group Test
- Alcoa Sponsors Ferrari Panamerican 20,000; The 84-Day Test Drive of the 599 GTB Fiorano Travels 16 Countries in South, Central and North America; Fiorano Has an Alcoa Aluminum Space Frame
- Volunteers Sought for Testing HIV Vaccine: UM Institute to Take Part in Research on GeoVax Product
- Thai Gov't to Vaccinate 150,000 Workers Against Influenza
User Comments (0)


RSS Feeds